Table 2.
Team familiarity and other determinants associated with adjusted surgical outcomes
| Composite adverse event | Major surgical complication | Unplanned reoperation | Extended ICU stay | Death | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Characteristic | Odds ratio (95% CI)c | P value | Odds ratio (95% CI)c | P value | Odds ratio (95% CI)c | P value | Odds ratio (95% CI)c | P value | Odds ratio (95% CI)c | P value |
| Surgical team familiaritya | 0.92 (0.87–0.98) | 0.007 | 0.93 (0.88–0.99) | 0.015 | 0.88 (0.78–0.99) | 0.027 | 0.88 (0.75–1.04) | 0.132 | 0.87 (0.74–1.03) | 0.101 |
| Attending surgeon age | 1.00 (0.99–1.02) | 0.807 | 1.00 (0.99–1.02) | 0.570 | 1.00 (0.98–1.02) | 0.906 | 1.00 (0.98–1.02) | 0.987 | 0.99 (0.96–1.02) | 0.505 |
| Attending surgeon status | ||||||||||
| Non-professor | - | - | - | - | - | |||||
| Associate/full professor | 0.95 (0.74–1.23) | 0.717 | 0.95 (0.73–1.24) | 0.696 | 0.92 (0.66–1.28) | 0.615 | 1.07 (0.72–1.59) | 0.723 | 0.85 (0.57–1.27) | 0.435 |
| Assisting surgeon status | - | - | - | - | - | |||||
| Junior | ||||||||||
| Senior | 1.35 (1.01–1.79) | 0.041 | 1.35 (1.00–1.82) | 0.049 | 1.22 (0.88–1.70) | 0.229 | 1.14 (0.84–1.56) | 0.393 | 1.25 (0.62–2.54) | 0.528 |
| Patient risk score quartile by surgical specialtyb | ||||||||||
| Cardiac and thoracic (Q1) | - | - | - | - | - | |||||
| Cardiac and thoracic (Q2) | 1.22 (0.64–2.29) | 0.545 | 1.29 (0.69–2.43) | 0.420 | 1.05 (0.31–3.57) | 0.940 | 1.07 (0.50–2.29) | 0.858 | 2.71 (1.19–6.16) | 0.017 |
| Cardiac and thoracic (Q3) | 1.69 (1.25–2.29) | <0.001 | 1.59 (1.20–2.09) | 0.001 | 2.90 (1.09–7.74) | 0.033 | 2.69 (1.16–6.24) | 0.021 | 6.16 (3.50–10.8) | <0.001 |
| Cardiac and thoracic (Q4) | 3.49 (2.35–5.17) | <0.001 | 3.21 (2.19–4.71) | <0.001 | 5.91 (1.94–18.0) | 0.002 | 5.81 (2.65–12.7) | <0.001 | 16.4 (10.9–24.5) | <0.001 |
| General and endocrine (Q1) | 0.22 (0.15–0.32) | <0.001 | 0.22 (0.14–0.33) | <0.001 | 0.38 (0.11–1.26) | 0.115 | 0.02 (0.00–0.13) | <0.001 | 0.23 (0.05–1.04) | 0.056 |
| General and endocrine (Q2) | 0.56 (0.36–0.85) | 0.006 | 0.56 (0.36–0.87) | 0.010 | 0.64 (0.18–2.29) | 0.495 | 0.11 (0.03–0.37) | <0.001 | 0.12 (0.02–0.88) | 0.037 |
| General and endocrine (Q3) | 0.92 (0.62–1.36) | 0.676 | 0.98 (0.66–1.44) | 0.912 | 1.16 (0.37–3.63) | 0.795 | 0.39 (0.15–1.01) | 0.052 | 0.99 (0.44–2.26) | 0.989 |
| General and Endocrine (Q4) | 3.25 (2.26–4.68) | <0.001 | 3.28 (2.29–4.70) | <0.001 | 4.02 (1.34–12.1) | 0.013 | 2.35 (1.01–5.47) | 0.048 | 5.24 (2.72–10.1) | <0.001 |
| Orthopedic and urogynecologic (Q1) | 0.08 (0.05–0.12) | <0.001 | 0.07 (0.04–0.11) | <0.001 | 0.13 (0.04–0.45) | 0.001 | 0.00 (0.00–0.00) | <0.001 | 0.08 (0.01–0.82) | 0.033 |
| Orthopedic and urogynecologic (Q2) | 0.17 (0.11–0.25) | <0.001 | 0.14 (0.09–0.22) | <0.001 | 0.38 (0.12–1.27) | 0.116 | 0.02 (0.00–0.17) | <0.001 | 0.13 (0.04–0.45) | 0.001 |
| Orthopedic and urogynecologic (Q3) | 0.33 (0.23–0.48) | <0.001 | 0.31 (0.22–0.45) | <0.001 | 0.62 (0.19–2.02) | 0.431 | 0.00 (0.00–0.00) | <0.001 | 0.00 (0.00–0.00) | <0.001 |
| Orthopedic and urogynecologic (Q4) | 0.96 (0.64–1.44) | 0.842 | 0.94 (0.62–1.42) | 0.767 | 1.64 (0.52–5.15) | 0.397 | 0.25 (0.07–0.93) | 0.039 | 1.16 (0.51–2.63) | 0.720 |
Surgical team familiarity was measured based on the number of previous collaborations between the attending and assisting surgeon and modeled using a logarithmic transformation.
Preoperative risk scores were developed for the five outcomes across the surgical specialties using a dataset of 3644 operations. The variables included demographics, surgical details, and comorbidities. Categories were based on quartiles (Q1-Q4) representing increasing adverse event rates by surgical specialty.
Abbreviations: CI = confidence interval.
We employed a multivariable generalized estimating equations (GEE) with an independent correlation matrix to model the association between patient outcomes and surgical team familiarity. The attending surgeon identity was considered in the models as a random effect, and possible interactions between the covariates were examined.